# EDGAR Filing Document

**Accession Number:** 0001954863
**File Stem:** 0001213900-25-103215
**Filing Date:** 2025-10
**Character Count:** 12535
**Document Hash:** 0c605c79dd297e3fd345c8b9911dcc28
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-103215.hdr.sgml**: 20251028

**ACCESSION NUMBER**: 0001213900-25-103215

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251028

**DATE AS OF CHANGE**: 20251028

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bioceres Crop Solutions Corp.
- **CENTRAL INDEX KEY:** 0001769484
- **STANDARD INDUSTRIAL CLASSIFICATION:** AGRICULTURE CHEMICALS [2870]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-90962
- **FILM NUMBER:** 251426446

**BUSINESS ADDRESS:**
- **STREET 1:** PO BOX 309, UGLAND HOUSE
- **CITY:** GEORGE TOWN, GRAND CAYMAN
- **STATE:** E9
- **ZIP:** KY1-1104
- **BUSINESS PHONE:** 54 341 486 1122

**MAIL ADDRESS:**
- **STREET 1:** OCAMPO 210 BIS, PREDIO CCT
- **CITY:** ROSARIO
- **STATE:** C1
- **ZIP:** 2000
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bioceres Group Ltd
- **CENTRAL INDEX KEY:** 0001954863

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** HIGHDOWN HOUSE, YEOMAN WAY
- **CITY:** WORTHING, WEST SUSSEX
- **PROVINCE COUNTRY:** X0
- **BUSINESS PHONE:** 5403414861100

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** HIGHDOWN HOUSE, YEOMAN WAY
- **CITY:** WORTHING, WEST SUSSEX
- **PROVINCE COUNTRY:** X0

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Bioceres Group PLC
- **DATE OF NAME CHANGE:** 20221116

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 17)**

**Bioceres Crop Solutions Corp.**

*(Name of Issuer)*

**Ordinary Shares, $0.0001 par value**

*(Title of Class of Securities)*

**G1117K114**

*(CUSIP Number)*

**Gloria Montaron Estrada**<br>Bioceres Group Limited<br>Highdown House, Yeoman Way, Worthing<br>West Sussex X0 BN99 3HH<br>54 0341 4861100

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**10/28/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **G1117K114** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Bioceres Group Limited** | Name of reporting person<br>**Bioceres Group Limited** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**—** | Source of funds (See Instructions)<br>**—** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X0** | Citizenship or place of organization<br>**X0** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**44161.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**6221079.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**44161.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**3145000.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**6265240.00** | Aggregate amount beneficially owned by each reporting person<br>**6265240.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**10%** | Percent of class represented by amount in Row (11)<br>**10%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**HC** | Type of Reporting Person (See Instructions)<br>**HC** | |

---

**Comment for Reporting Person:** (1) Bioceres Group Limited may be deemed to be the ultimate beneficial owner of Shares held by Bioceres LLC as Bioceres LLC is an indirect wholly-owned subsidiary of Bioceres Group Limited.

(2) Includes 3,076,079 shares that Bioceres LLC has shareholder rights over pursuant to the Shareholders Agreement, dated as of March 5, 2019, by and between Bioceres LLC, Pedro Enrique Mac Mullen, Maria Marta Mac Mullen and International Property Services Corp. See Exhibit 10.1.

| **CUSIP No.** | **G1117K114** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Bioceres LLC** | Name of reporting person<br>**Bioceres LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**—** | Source of funds (See Instructions)<br>**—** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**6221079.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**3145000.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**6221079.00** | Aggregate amount beneficially owned by each reporting person<br>**6221079.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**9.9%** | Percent of class represented by amount in Row (11)<br>**9.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**HC** | Type of Reporting Person (See Instructions)<br>**HC** | |

---

**Comment for Reporting Person:** (1) Bioceres LLC is an indirect wholly-owned subsidiary of Bioceres Group Limited. As a result, Bioceres Group Limited may be deemed to be the ultimate beneficial owner of Shares held by Bioceres LLC

(2) Includes 3,076,079 shares that Bioceres LLC has shareholder rights over pursuant to the Shareholders Agreement, dated as of March 5, 2019, by and between Bioceres LLC, Pedro Enrique Mac Mullen, Maria Marta Mac Mullen and International Property Services Corp. See Exhibit 10.1.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Ordinary Shares, $0.0001 par value

**(b) Name of Issuer:**
Bioceres Crop Solutions Corp.

**(c) Address of Issuer's Principal Executive Offices:**
OCAMPO 210 BIS,, ROSARIO, C1, 2000

EXPLANATORY NOTE

This Amendment No. 17 (the "Amendment") amends and supplements the Schedule 13D filed with the Securities and Exchange Commission (the "SEC") on March 14, 2019, (as amended by Amendment No. 1 filed with the SEC on July 2, 2020, Amendment No. 2 filed with the SEC on August 28, 2020, Amendment No. 3 filed with the SEC on November 25, 2020, Amendment No. 4 filed with the SEC on August 6, 2021, Amendment No. 5 filed with the SEC on October 15, 2021, Amendment No. 6 filed with the SEC on April 5, 2022, Amendment No. 7 filed with the SEC on July 25 2022, Amendment No. 8 filed with the SEC on November 15, 2022, Amendment No. 9 filed with the SEC on March 25, 2024, Amendment No. 10 filed with the SEC on September 20, 2024, Amendment No. 11 filed with the SEC on January 6, 2025, Amendment No. 12 filed with the SEC on March 26, 2025, Amendment No. 13 filed with the SEC on June 6, 2025, Amendment No. 14 filed with SEC on July 9, 2025, and Amendment No. 15 filed with SEC on August 7, 2025, and Amendment No. 16 filed with SEC on September 17, 2025 (the "Schedule 13D"), by Bioceres Group Limited and Bioceres LLC (each a "Reporting Person", and herein collectively referred as the "Reporting Persons").

This Amendment is being filed to report a decrease in the Shares beneficially owned by the Reporting Persons as a result of the settlement of certain financial obligations through payment-in-kind made in Shares relating to private transactions (the "Transaction"). As a result of the foregoing, the Shares owned by the Reporting Persons decreased from 9,432,896 to 3,189,161.

The Items below amend the information disclosed under the corresponding Items of the Schedule 13D as described below. Except as expressly amended and supplemented by this Amendment, the Schedule 13D is not amended or supplemented in any respect. Capitalized terms used but not otherwise defined in this Amendment have the meanings ascribed to such terms in the Schedule 13D.

The aggregate percentages of Shares beneficially owned by the Reporting Persons, and reported in this Amendment, is calculated based on 62,848,483 Shares outstanding, as reported by the Issuer in its annual report on Form 20-F filed with the SEC on October 30, 2024 (File No. 001-38836) (the "Issuer 20-F").

**Item 4. Purpose of Transaction**

The purpose of the Transaction was to fund the payment of financial obligations which were due.

As a result of the Transaction, the Shares owned by the Reporting Persons, which are not subject to the shareholders' agreement described under Item 6 of the Schedule 13D, decreased from 9,432,896 Shares to 3,189,161 Shares. In addition, 3,076,079 Shares which the Reporting Persons have the shared power to vote or to direct the vote of are subject to the shareholders' agreement described under Item 6 of the Schedule 13D. As a result of the foregoing, in the aggregate, the Reporting Persons beneficially own 6,265,240 Shares (corresponding to approximately 10% of the Issuer's outstanding capital stock).

Except for the foregoing, the Reporting Persons have no plans or proposals which relate to, or could result in, any of the matters referred to in Item 4 of Schedule 13D.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Bioceres Group Limited
a) Amount beneficially owned: 6,265,240
Percentage: 10%

Bioceres LLC
a) Amount beneficially owned: 6,221,079
Percentage: 9.9%

**(b)**
Bioceres Group Limited
b) Number of shares to which the Reporting Person has:i. Sole power to vote or to direct the vote: 44,161ii. Shared power to vote or to direct the vote: 6,221,079iii. Sole power to dispose or to direct the disposition of: 44,161iv. Shared power to dispose or to direct the disposition of: 3,145,000

Bioceres LLC
b) Number of shares to which the Reporting Person has:i. Sole power to vote or to direct the vote: --ii. Shared power to vote or to direct the vote: 6,221,079iii. Sole power to dispose or to direct the disposition of: --iv. Shared power to dispose or to direct the disposition of: 3,145,000

**(c)**
None of the Reporting Persons has effected any transactions of the Issuer's Shares during the 60 days preceding the date of this report, except as described in Item 4 of this Schedule 13D/A which information is incorporated herein by reference.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Bioceres Group Limited

**Signature:** /s/ Gloria Montaron Estrada

**Name/Title:** Gloria Montaron Estrada/Attorney-in-Fact

**Date:** 10/28/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Bioceres LLC

**Signature:** /s/ Gloria Montaron Estrada

**Name/Title:** Manager

**Date:** 10/28/2025